Idiopathic Pulmonary Fibrosis Forecast and Market Analysis 2018-2035 - Ofev will Succeed Esbriet as Market Leader
Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Forecast and Market Analysis for 2035" drug pipelines has been added to ResearchAndMarkets.com's offering. Idiopathic pulmonary fibrosis (IPF) is a type of …